Rheumatoid Arthritis Disease Activity Boosts Coronary Risks
Acute coronary syndrome incidence has declined but remains significantly higher in patients with rheumatoid arthritis.
Should We Refer Symptomatic HF Patients for AF Ablation?
That depends, as suggested by results of the CASTLE-AF study, presented at ESC Congress 2017, in Barcelona, Spain.
AF Screening Leads the Charge in Cardiology's Digital Revolution
Diagnosis of atrial fibrillation via handheld iECG monitor looks promising but can we pay for it yet?
The Artificial Sweetener Paradox: Weight Gain and Metabolic Dysfunction?
A new meta-analysis finds that routine intake of artificial sweeteners is linked to the opposite of the intended effect.
Could AF Ablation have a "Placebo" Effect?
A small study raises big questions about patients' perceptions of AF symptoms after pulmonary vein ablation. What do you think?
Subclinical Atrial Fibrillation Rears its Head, Again
Increased detection of subclinical atrial fibrillation intensifies a common clinical quandary in AF patients: to anticoagulate, or not?
Hydroxychloroquine for Lupus Thins Thrombosis Risk
Long-term use of HCQ and low dose aspirin may work to reduce cardiovascular events.
Which is safer? Celecoxib? Naproxen? Ibuprofen?
The long-awaited results from the PRECISION trial are in — with some caveats. In this slideshow, we summarize the results.
By clicking Accept, you agree to become a member of the UBM Medica Community.